Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline

View ORCID ProfileJames Baxter, Ch. Julián Villabona Arenas, Robin N. Thompson, Stéphane Hué, Roland R. Regoes, Roger D. Kouyos, Huldrych F. Günthard, Jan Albert, Andrew Leigh Brown, Katherine E. Atkins
doi: https://doi.org/10.1101/2024.03.14.24304300
James Baxter
1Usher Institute, Edinburgh Medical School, The University of Edinburgh, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James Baxter
  • For correspondence: james.baxter{at}ed.ac.uk
Ch. Julián Villabona Arenas
2Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
3Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin N. Thompson
4Mathematical Institute, University of Oxford, Oxford OX2 6GG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stéphane Hué
2Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
3Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland R. Regoes
5Department of Environmental Systems Science, Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger D. Kouyos
6Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
7Institute of Medical Virology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huldrych F. Günthard
6Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
7Institute of Medical Virology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Albert
8Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
9Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Leigh Brown
10Institute of Evolutionary Ecology, The University of Edinburgh, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine E. Atkins
1Usher Institute, Edinburgh Medical School, The University of Edinburgh, Edinburgh, United Kingdom
2Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
3Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Three quarters of new HIV-1 infections are reported to be initiated by a single genetic variant. Infections initiated by multiple variants have been linked with higher recipient set point viral loads (SpVL) and a faster rate of CD4+ T cell decline, indicative of a worse clinical prognosis if left untreated. These findings have not been universally replicated, however, and a mechanism through which multiple variants might lead to a worse prognosis is yet to be elucidated. In this study, we first summarised the existing evidence for this ‘dose response’ phenomenon for HIV-1, and quantified how likely we are to observe a true difference in set point viral load between multiple and single variant infections. Next, we considered whether the association between higher SpVL and multiple variant infection could exist in the absence of a causal mechanism. For a fixed diversity, high transmitter SpVL could simultaneously lead to high recipient SpVL through the inheritance of a ‘high virulence’ genotype and a greater probability that recipient infection is initiated by multiple genetic variants. Nonetheless, a high transmitter SpVL also shortens the duration of infection, consequently reducing the likelihood of the higher SpVL individual transmitting and restricting the overall accumulation of viral diversity. We combined data-driven models of transmission, heritability and HIV-1 disease progression to test whether an association between multiple variant infection and clinical progression is expected. First, we found that we are unlikely to record a significant difference in SpVL between multiple and single variant infections, at frequencies of multiple variant infections consistent with empirical observations. Second, we found that we would not expect multiple variant infections to lead to higher SpVL or faster CD4+ T cell decline without a causal mechanism. Specifically, the probability that infection is initiated by multiple variants is greatest at the highest transmitter SpVLs, yet the relationship between transmitter and recipient SpVL is relatively weak. This finding supports the hypothesis that a within-patient causal mechanism is required to explain the association of multiple variant infection with higher viral loads and faster CD4+ T cell decline. Further investigation into events happening during and just after transmission are required to enhance our understanding of this association.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

JB was supported by the Medical Research Council Precision Medicine Doctoral Training Grant (2016 to 2021; MR/N013166/1); KEA was funded by a European Research Council Starting Grant (award number 757688).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The data used to fit the heritability model from the Swiss HIV Cohort Study are available from the corresponding author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted March 16, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline
James Baxter, Ch. Julián Villabona Arenas, Robin N. Thompson, Stéphane Hué, Roland R. Regoes, Roger D. Kouyos, Huldrych F. Günthard, Jan Albert, Andrew Leigh Brown, Katherine E. Atkins
medRxiv 2024.03.14.24304300; doi: https://doi.org/10.1101/2024.03.14.24304300
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline
James Baxter, Ch. Julián Villabona Arenas, Robin N. Thompson, Stéphane Hué, Roland R. Regoes, Roger D. Kouyos, Huldrych F. Günthard, Jan Albert, Andrew Leigh Brown, Katherine E. Atkins
medRxiv 2024.03.14.24304300; doi: https://doi.org/10.1101/2024.03.14.24304300

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • HIV/AIDS
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)